Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
naganishia albida lysate
- Development stage
- Unknown
01
Overview
No specific information regarding 'naganishia albida lysate' was found in the provided context. The context discusses lysates from other yeast strains, specifically Rhodotorula mucilaginosa and Cryptococcus laurentii, which were isolated from human breast milk and evaluated for their anti-colon cancer effects and probiotic potential. These other yeast lysates demonstrated inhibition of colon cancer cell proliferation and induction of apoptosis and autophagy.
Beyond the preview
Go deeper on naganishia albida lysate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on naganishia albida lysate.